Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients

Öncü, Mehmet; Akta, R.; Gizli, G.; Bilvanisi, S.; Yildiz, H.; Baran, A.

doi:10.26355/eurrev_202206_29084

Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients

Copy For Citation

Öncü M. R., Akta R. S., Gizli G., Bilvanisi S., Yildiz H., Baran A.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.26, no.12, pp.4449-4455, 2022 (SCI-Expanded)

Publication Type: Article / Article
Volume: 26 Issue: 12
Publication Date: 2022
Doi Number: 10.26355/eurrev_202206_29084
Journal Name: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Page Numbers: pp.4449-4455
Keywords: COVID-19, ABO blood groups, Comorbid diseases, Mortality
Van Yüzüncü Yıl University Affiliated: Yes

Abstract

OBJECTIVE: This study aimed to investigate the mortality relationship between COVID-19 and ABO blood groups and comorbid diseases. The aim of this study was to determine whether ABO blood groups and comorbid diseases can be used as a prognostic factor for hospitalization.